概要
Click Here to View the Flyer in Japanese
Online Registration has been closed. Onsite Registration will be available at TKP Tokyo Station Yaesu Conference Center.
プログラム委員会
-
Tomoaki Sakamoto, PhD Section Chief, Division of Drugs
National Institute of Health Sciences, Japan -
Rie Fujita Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Takeshi Hamaura, PhD Head of Pharmaceutical Technology Division
Daiichi Sankyo Co., Ltd., Japan -
Fusashi Ishikawa, PhD, MSc Associate Biopharmaceutics Research Fellow, Formulation R&D Laboratories
Sumitomo Dainippon Pharma Co., Ltd., Japan -
Motonori Kidokoro, PhD Director, Regulatory Affairs CMC
Daiichi Sankyo Pharma Development, United States -
Hitomi Koro Reviewer, Office of Cellular and Tissue-based Products
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yuko Nagai Manager, Regulatory Affairs Office, Quality & Pharmacovigilance Division
Nippon Kayaku Co., Ltd., Japan -
Yoshio Nakayama Regulatory Scientist, CM&C Regulatory Affairs, Japan Regulatory Affairs
Eli Lilly Japan K.K., Japan -
Hiroko Shibata Senior Researcher, Division of Drugs
National Institute of Health Sciences, Japan -
Yutaka Takahashi Senior Manager, Pharmaceutical Planning & Control
Astellas Pharma Inc., Japan -
Satomi Yagi Reviewer, Office of New Drug III
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Yukio Hiyama, PhD Visiting Researcher
National Institute of Health Sciences, Japan
